-
Searching Blood for Cancer Clues
Researchers are developing blood tests that help track and identify molecular changes in tumors. But many hurdles remain before these “liquid biopsies” become standard.
by Stephen Ornes
-
Liver Cancer on the Rise
Liver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.
by Sue Rochman
-
Gaps in End-of-Life Care
Racial and ethnic backgrounds can be factors in whether cancer patients take advantage of hospice care. Researchers and clinicians are trying to understand the gaps and design strategies to bridge them.
by Charlotte Huff
-
Online Discussions Reveal Little-Known Side Effects
Analyzing online patient conversations could shed light on adverse drug reactions.
by Brad Jones
-
Is 3-D Mammography Better?
A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.
by Marci A. Landsmann
-
When Cancer Survivors Get Another Cancer
Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
-
Targeting Brain Cancer
Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
-
Healthy Habits
A Bacterial LinkThe microbes living in your gut may explain how diet influences colorectal cancer risk.
by Lori Miller Kase
-
Healthy Habits
Another Reason to FlossGum disease is associated with increased cancer risk.
by Kendall K. Morgan
-
Q&A
Why Fat MattersCancer epidemiologist Cornelia Ulrich discusses research that explores how fat cells and cancer cells communicate.
by Marci A. Landsmann
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles